Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Abstract Glioblastoma (GBM) as the most common primary malignant brain tumor exhibits a high incidence and degree of malignancy as well as poor prognosis. Due to the existence of formidable blood–brain barrier (BBB) and the aggressive growth and infiltrating nature of GBM, timely diagnosis and treat...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2022-06-01
|
| Col·lecció: | Journal of Nanobiotechnology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12951-022-01479-6 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|